TAS attenuated endothelial dysfunction through the activation of PI3K/Akt signalling, followed by regulating the levels of inflammatory factors and the expression of Bcl-2 family proteins, such as Bax and Bcl-2, which led to decreased levels of activated caspase-3. The gene discussed is AKT1; the disease is endothelial dysfunction.